OPKO Health

$4.55
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (+1.81%) Today

+$0.05 (+1.11%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell OPKO Health and other stocks, options, and ETFs commission-free!

About OPK

OPKO Health, Inc. Common Stock, also called OPKO Health, is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment include clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL. The listed name for OPK is OPKO Health, Inc. Common Stock.

CEO

Phillip Frost

Employees

5,269

Headquarters

Miami, Florida

Founded

1991

Market Cap

3.12B

Price-Earnings Ratio

92.66

Dividend Yield

—

Average Volume

8.65M

High Today

$4.66

Low Today

$4.43

Open Price

$4.61

Volume

6.66M

52 Week High

$6.47

52 Week Low

$1.12

OPK News

BenzingaFeb 22

Insider Buys OPKO Health's Shares

Chairman Frost Phillip Md Et Al filed a Form 4 with the SEC on Monday, February 22. The insider bought 28,802 shares of OPKO Health Inc (NASDAQ:OPK) at an avera

BenzingaFeb 22

ROCE Insights For OPKO Health

Looking at Q4, OPKO Health (NASDAQ:OPK) earned $49.36 million, a 124.97% increase from the preceding quarter. OPKO Health also posted a total of $494.60 million

OPK Earnings

-$0.11

-$0.06

-$0.00

$0.05

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

$0.04 per share

Actual

$0.05 per share

Replay Earnings Call